Point72 Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.2M | Sell |
257,298
-960,309
| -79% | -$66.9M | 0.02% | 928 |
|
|
2025
Q4 | $80.8M | Sell |
1,217,607
-1,018,380
| -46% | -$65.8M | 0.09% | 242 |
|
|
2025
Q3 | $150M | Buy |
+2,235,987
| New | +$177M | 0.25% | 68 |
|
|
2025
Q2 | – | Sell |
-386,904
| Closed | -$30.3M | – | 2294 |
|
|
2025
Q1 | $26.4M | Sell |
386,904
-1,211,951
| -76% | -$98.9M | 0.06% | 372 |
|
|
2024
Q4 | $124M | Buy |
+1,598,855
| New | +$118M | 0.27% | 77 |
|
|
2023
Q4 | – | Sell |
-813,058
| Closed | -$83.1M | – | 2311 |
|
|
2023
Q3 | $75.9M | Buy |
813,058
+792,140
| +3,787% | +$89.3M | 0.22% | 93 |
|
|
2023
Q2 | $2.69M | Sell |
20,918
-1,541,082
| -99% | -$186M | 0.01% | 977 |
|
|
2023
Q1 | $181M | Buy |
1,562,000
+1,359,165
| +670% | +$152M | 0.56% | 23 |
|
|
2022
Q4 | $23M | Sell |
202,835
-627,528
| -76% | -$68.9M | 0.08% | 307 |
|
|
2022
Q3 | $66.9M | Sell |
830,363
-78,446
| -9% | -$6.64M | 0.27% | 90 |
|
|
2022
Q2 | $67.7M | Buy |
+908,809
| New | +$82.9M | 0.29% | 82 |
|
|
2021
Q2 | – | Sell |
-128,000
| Closed | -$11.5M | – | 1014 |
|
|
2021
Q1 | $11.5M | Sell |
128,000
-678,400
| -84% | -$63.7M | 0.05% | 398 |
|
|
2020
Q4 | $74.5M | Buy |
806,400
+205,140
| +34% | +$18.3M | 0.36% | 55 |
|
|
2020
Q3 | $62M | Buy |
601,260
+541,260
| +902% | +$56.5M | 0.32% | 75 |
|
|
2020
Q2 | $6.08M | Buy |
60,000
+12,812
| +27% | +$1.15M | 0.04% | 447 |
|
|
2020
Q1 | $3.18M | Sell |
47,188
-432,668
| -90% | -$26.9M | 0.03% | 443 |
|
|
2019
Q4 | $26.2M | Sell |
479,856
-430,184
| -47% | -$20.4M | 0.14% | 208 |
|
|
2019
Q3 | $34M | Sell |
910,040
-280,548
| -24% | -$10.9M | 0.21% | 138 |
|
|
2019
Q2 | $44.6M | Buy |
1,190,588
+514,260
| +76% | +$16.2M | 0.23% | 111 |
|
|
2019
Q1 | $20.1M | Buy |
676,328
+418,672
| +162% | +$14.7M | 0.09% | 249 |
|
|
2018
Q4 | $7.72M | Sell |
257,656
-1,559,012
| -86% | -$49.5M | 0.04% | 455 |
|
|
2018
Q3 | $65M | Sell |
1,816,668
-3,084,708
| -63% | -$95.6M | 0.27% | 100 |
|
|
2018
Q2 | $116M | Buy |
4,901,376
+984,676
| +25% | +$20.9M | 0.46% | 47 |
|
|
2018
Q1 | $72.6M | Buy |
3,916,700
+3,516,700
| +879% | +$52M | 0.3% | 87 |
|
|
2017
Q4 | $5.74M | Sell |
400,000
-120,000
| -23% | -$1.56M | 0.02% | 564 |
|
|
2017
Q3 | $6.36M | Sell |
520,000
-978,264
| -65% | -$17.3M | 0.03% | 497 |
|
|
2017
Q2 | $27.4M | Buy |
1,498,264
+1,319,636
| +739% | +$24.4M | 0.15% | 182 |
|
|
2017
Q1 | $3.78M | Sell |
178,628
-591,772
| -77% | -$11.6M | 0.02% | 588 |
|
|
2016
Q4 | $11.5M | Buy |
770,400
+36,000
| +5% | +$638K | 0.08% | 283 |
|
|
2016
Q3 | $16.1M | Sell |
734,400
-309,600
| -30% | -$6.89M | 0.11% | 219 |
|
|
2016
Q2 | $20.7M | Buy |
1,044,000
+12,400
| +1% | +$211K | 0.14% | 176 |
|
|
2016
Q1 | $17.5M | Buy |
1,031,600
+132,800
| +15% | +$2.22M | 0.13% | 188 |
|
|
2015
Q4 | $18.4M | Buy |
+898,800
| New | +$18.7M | 0.15% | 174 |
|
Other funds holding DXCM
VCM
VPM
Point72 Asset Management's DXCM Position: Q1 2026 in Review
Point72 Asset Management reduced its DexCom (DXCM) stake by 79% in Q1 2026, selling an estimated $66.9M and leaving 257,298 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #928.
Point72 Asset Management first reported a position in DXCM in Q4 2015 and has held it in 33 quarters since. The position peaked at $181M in Q1 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Point72 Asset Management held 257,298 shares of DexCom worth $16.2M as of Q1 2026.
- Point72 Asset Management sold 960,309 DexCom shares in Q1 2026, an estimated $66.9M.
- DexCom made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #928 holding.
- Point72 Asset Management first reported a position in DexCom in Q4 2015 and has held it in 33 quarters since.
- Point72 Asset Management's DexCom position peaked at $181M in Q1 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.